Search Results
May 07, 2026, 16:15 ET FS Specialty Lending Fund (FSSL) Declares Distribution for May 2026
these funds, including uncalled investor capital commitments from which Future Standard is currently not earning management fees or carried interest; (iii) the value of outstanding CLOs (excluding CLOs wholly-owned by Future Standard); (iv) the fair value of FS KKR Capital Corp. joint venture (JV) assets
More news about: Future Standard
May 07, 2026, 16:15 ET Drilling Tools International Corp. Reports 2026 First Quarter Results
depreciation and amortization, further adjusted for (i) goodwill and/or long-lived asset impairment charges, (ii) stock-based compensation expense, (iii) restructuring charges, (iv) transaction and integration costs related to acquisitions and (v) other expenses or charges to exclude certain items that
More news about: Drilling Tools International Corp.
May 07, 2026, 16:15 ET Nektar Therapeutics Reports First Quarter 2026 Financial Results
including negative safety and efficacy findings in future clinical studies (notwithstanding positive findings in earlier preclinical and clinical studies); (iii) rezpegaldesleukin, NKTR-0165, NKTR-0166 and NKTR-422 are in clinical development and the risk of failure is high and can unexpectedly occur at any stage
More news about: Nektar Therapeutics
May 07, 2026, 16:15 ET MSC INCOME FUND ANNOUNCES FIRST QUARTER 2026 RESULTS
increase was principally attributable to (i) a $0.7 million increase in interest expense, (ii) a $0.3 million increase in base management fees and (iii) a $0.1 million increase in incentive fee on income, net of waivers, partially offset by a $0.6 million decrease in the ending accrual for the accrued
More news about: MSC Income Fund, Inc.
May 07, 2026, 16:15 ET American Healthcare REIT Announces First Quarter 2026 Results; Increases Full Year 2026 Guidance
an indicator of our operating performance, (ii) more relevant or accurate than GAAP cash flows from operations as an indicator of our liquidity or (iii) indicative of funds available to fund our cash needs, including our ability to make distributions to our stockholders. The method utilized to evaluate
More news about: American Healthcare REIT, Inc.
May 07, 2026, 16:15 ET Post Holdings Reports Results for the Second Quarter of Fiscal Year 2026; Affirms Fiscal Year 2026 Outlook
assets, (ii) it presents a measure of corporate performance exclusive of Post's capital structure and the method by which the assets were acquired and (iii) it is a financial indicator of a company's ability to service its debt, as Post is required to comply with certain covenants and limitations that are
More news about: Post Holdings, Inc.
May 07, 2026, 16:14 ET Saul Centers, Inc. Reports First Quarter 2026 Earnings
disruptions, which may lead to a disruption of, or lack of access to, sources of funding and rising inflation, (ii) the ability of our tenants to pay rent, (iii) our reliance on shopping center "anchor" tenants and other significant tenants, (iv) our substantial relationships with members of the B. F. Saul Company
More news about: Saul Centers, Inc.
May 07, 2026, 16:05 ET Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
Ginkgo operates and plans to operate, variations in performance across competitors, and changes in laws and regulations affecting Ginkgo's business, (iii) the ability to implement business plans, forecasts, and other expectations, and to identify and realize additional business opportunities, including
More news about: Ginkgo Bioworks
May 07, 2026, 16:05 ET Lauber highlights exceptional year for WEC Energy Group
stockholders elected the following directors to terms expiring at the 2027 annual meeting: Warner L. Baxter, Ave M. Bie, Danny L. Cunningham, William M. Farrow III, Cristina A. Garcia-Thomas, Maria C. Green, Thomas K. Lane, John D. Lange, Scott J. Lauber, Ulice Payne Jr., Mary Ellen Stanek and Glen E. Tellock.As
More news about: WEC Energy Group
May 07, 2026, 16:03 ET BioLife Solutions Reports First Quarter 2026 Financial Results
approximately 250 ongoing commercially sponsored clinical trials in the U.S., representing a more than 70% market share. This includes over 30 Phase III trials, or nearly 80% of these late-stage trials. Our CellSeal vials and hPL products are used in over 35 clinical trials.Our biopreservation
More news about: BioLife Solutions, Inc.
May 07, 2026, 16:01 ET BRC Group Holdings, Inc. Reports First Quarter 2026 Financial Results
gains (losses), net and fair value adjustments on loans, less fixed income spread and trading gains attributable to variable rate transaction spread (iii) excluding in the case of Adjusted EBITDA, net interest expense, provisions for or benefit from income taxes, depreciation, amortization, restructuring
More news about: BRC Group Holdings, Inc.
May 07, 2026, 16:01 ET Wynn Resorts, Limited Reports First Quarter 2026 Results
Wynn Resorts, Limited to adjusted net income attributable to Wynn Resorts, Limited, (ii) operating income (loss) to Adjusted Property EBITDAR, and (iii) net income attributable to Wynn Resorts, Limited to Adjusted Property EBITDAR.
More news about: Wynn Resorts, Limited
May 07, 2026, 15:59 ET Try ActivatedYou Morning Complete To Upgrade Your Hydration for Drinking Water Week: The All-In-One "Water Stacking" Alternative for Full-Body Wellness
Qeep Up, ActivatedYou founder, and actor — best known for her roles in Ballad, Nikita, Designated Survivor, and Mission: Impossible III — Maggie Q uses her name to advocate for those in need. Maggie's personal health struggles led her to conduct extensive research in nutrition and inspired
More news about: ActivatedYou
May 07, 2026, 14:25 ET Massage Envy Celebrates National Award Winners at 2026 Annual Performance Summit
national winners are announced. The following awards were presented for the 2025 calendar year:National Therapist of the Year: John Nappi, III, Massage Therapist at
More news about: Massage Envy
May 07, 2026, 13:00 ET Why You Don't Feel Loved (Even When You Are)
artists, and collaborators for conversations that challenge perspectives and deepen connections. Past Spark Salon speakers have included illusionist Harris III, psychologist Scott Barry Kaufman, PhD, nutrition therapist Kim Shapira, MS, RD, mythologist John Bucher, Harvard Business School professor and author
More news about: Unlikely Collaborators
May 07, 2026, 11:15 ET ACLM Announces 2026 Lifestyle Medicine Annual Conference Focused on Health Restoration and Care Transformation
experience for me to connect with like-minded medical students and residents, as well as professionals in lifestyle medicine," said Paige Stearn Juriga, OMS-III. "It was a way for me to see how I can truly incorporate lifestyle medicine into my future practice…so inspirational! The conference excited me about
More news about: American College of Lifestyle Medicine
May 07, 2026, 11:00 ET Level99 Announces Summer Opening, Job Opportunities at Disney Springs
www.level99.com.About Act III HoldingsAct III Holdings is a $2 billion evergreen investment vehicle formed by Ron Shaich, founder and former Chair and Chief Executive Officer of Panera Bread and current Chairman and lead investor of Cava. Act III holds significant investments and
More news about: Level99
May 07, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Pinterest, Inc. and Certain Officers - PINS
States ("U.S.") tariffs on the macroeconomic environment in which the Company operated, including the foreseeable impact on its advertising partners; (iii) the impact of the foregoing on Pinterest's advertising revenues was significant enough that Pinterest was facing and/or likely to face an imminent restructuring;
More news about: Pomerantz LLP
May 07, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines - IMMP
action] On March 13, 2026, Immutep issued a press release "announc[ing] that the Independent Data Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod alfa ('efti') in patients in 1st line non-small cell lung cancer has recommended the discontinuation of the trial
More news about: Pomerantz LLP
May 07, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics and Certain Officers - NKTR
applicable instructions and protocol standards; (ii) the foregoing was likely to have a significant negative impact on the REZOLVE-AA trial's results; (iii) accordingly, the REZOLVE-AA trial's overall integrity and prospects were overstated; and (iv) as a result, Defendants' public statements were materially
More news about: Pomerantz LLP
May 07, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers - ATRA
ALLELE study, made it unlikely that the FDA would approve the tabelecleucel BLA; (ii) accordingly, tabelecleucel's regulatory prospects were overstated; (iii) the aforementioned manufacturing issues also subjected Atara to a heightened risk of regulatory scrutiny, as well as jeopardized its ongoing clinical
More news about: Pomerantz LLP
May 07, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Upstart Holdings, Inc. and Certain Officers - UPST
performing its risk-separation processes; (ii) accordingly, Model 22's overall accuracy and propensity to increase loan approval rates was overstated; (iii) Model 22's overly conservative assessment of credit and macroeconomic conditions was having a significant negative impact on Upstart's revenue results,
More news about: Pomerantz LLP
May 07, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Gemini Space Station, Inc. and Certain Officers - GEMI
platform; (ii) Gemini had overstated its commitment to and/or the viability of growing its business through expanding its international operations; (iii) accordingly, Gemini's post-IPO financial and business prospects were overstated; (iv) all of the foregoing raised a non-speculative risk that Gemini
More news about: Pomerantz LLP
May 07, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC
manipulation; (ii) the resulting volatility in the market for the Company's ordinary shares exposed Regencell's investors to significant financial risk; (iii) all the foregoing subjected Regencell to a heightened risk of regulatory and/or governmental scrutiny and enforcement action, as well as significant
More news about: Pomerantz LLP
May 07, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Babcock & Wilcox Enterprises, Inc. and Certain Officers - BW
Applied Digital did not need the products and services that B&W would purportedly supply pursuant to the Power Generation LNTP and Contract; (iii) the foregoing, at the very least, would raise questions about the parties' actual intent behind entering into the Power Generation LNTP and Contract,
More news about: Pomerantz LLP